On Thursday, the California Institute for Regenerative Medicine -- the state's stem cell research funding agency -- granted a total of $151 million to eight research projects, the San Francisco Chronicle reports.
CIRM approved the funds at the agency's annual grant review meeting in Burlingame.
The grants will go toward research that is expected to lead to human clinical trials within the next four years.
The grants include:
- $20 million for research on heart failure;
- $20 million for research on a treatment for severe combined immune deficiency;
- $19 million for research on Huntington's disease; and
- $18 million for research on amyotrophic lateral sclerosis, or Lou Gehrig's disease.
Other grants will go toward research on cancer and spinal cord injuries, as well as studies on stimulating blood vessel growth and directing patients' own stem cells to form new bone (Allday, San Francisco Chronicle